NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Neupulse

Neupulse

Private
NottinghamHealthcare & Life Scienceshttps://neupulse.co/en-us

Last Round

Early Funding

Feb 13, 2026

Total Funding Raised

$7.65M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Neupulse is a healthtech company that develops a wearable neuromodulation device designed to reduce tics for individuals with Tourette's Syndrome.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2C

Customer Profile

Hardware + Subscription

AI Layer

Non-AI

Keywords

neuromodulationTourette's syndromemedical wearabletic disorder treatmentnerve stimulationmedian nerve stimulationMNSnon-invasive therapybioelectronic medicineneurotechdigital healthmovement disorder supporthealth IoTwearable tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neupulse Comps

Public and private peers based on sector, stage, and business model.

Neupulse comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Neupulse Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingFeb 13, 2026
SeedJul 31, 2024
SeedMar 18, 2024

Key People

Founding team and executive leadership

Paul Cable

Chief Executive Officer

Executive Team

David Moser

Chief Technology Officer

Executive Team

Neupulse Investors

Notable investors and investment history

Neupulse investors
InvestorRounds
British Business BankSeed, Early Funding
Mercia VenturesEarly Funding, Seed
Eos AdvisoryEarly Funding, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 13, 2026

    $3.8M raised in early funding.

  • Jan 4, 2026

    Preparing for EU MDR and FDA submissions for market entry.

Neupulse Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neupulse Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neupulse's valuation, stock price, and market status.

Firmographic Details

HeadquartersNottingham
Employee Range13
Year Founded2021
Last FundingFeb 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.